Metformin cuts cardio events in high-risk type 2 diabetes
(HealthDay)—Metformin therapy significantly reduces cardiovascular events in high-risk patients with type 2 diabetes compared to treatment with glipizide, according to a study published online Dec. 10 in Diabetes Care.
Jan 8, 2013
0
0